Product
dorzolamide/timolol
Aliases
Glaucotensil TD
2 clinical trials
3 indications
Indication
GlaucomaIndication
Open-AngleIndication
ocular hypertensionClinical trial
Phase IV, Multicenter, Double-blind, Randomized, Controlled, Parallel-group, Trial to Evaluate the Efficacy and Safety of Dozolamide 2%/Timolol 0,5% PF vs Dorzolamide 2%/Timolol 0,5% BAK-preserved in OAG or OHStatus: Recruiting, Estimated PCD: 2024-10-04
Clinical trial
Cross-over Comparison of Latanoprost QOD With Dor-tim QAM to Tim-brim-dor-bim(Atoprost) qd or Lat QD With Dor-tim BIDStatus: Recruiting, Estimated PCD: 2024-07-01